118 related articles for article (PubMed ID: 33401284)
1. Combinatorial Strategies for Long-term Control of HIV Infection.
Kwon D; Han MJ; Seo KW; Kang KS
AIDS Rev; 2020 Dec; 22(4):175-182. PubMed ID: 33401284
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia.
Xu L; Wang J; Liu Y; Xie L; Su B; Mou D; Wang L; Liu T; Wang X; Zhang B; Zhao L; Hu L; Ning H; Zhang Y; Deng K; Liu L; Lu X; Zhang T; Xu J; Li C; Wu H; Deng H; Chen H
N Engl J Med; 2019 Sep; 381(13):1240-1247. PubMed ID: 31509667
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evaluation of a Novel TALEN Targeting CCR5 Confirms Efficacy and Safety in Conferring Resistance to HIV-1 Infection.
Romito M; Juillerat A; Kok YL; Hildenbeutel M; Rhiel M; Andrieux G; Geiger J; Rudolph C; Mussolino C; Duclert A; Metzner KJ; Duchateau P; Cathomen T; Cornu TI
Biotechnol J; 2021 Jan; 16(1):e2000023. PubMed ID: 33103367
[TBL] [Abstract][Full Text] [Related]
4. CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape.
Hütter G; Bodor J; Ledger S; Boyd M; Millington M; Tsie M; Symonds G
Viruses; 2015 Jul; 7(8):4186-203. PubMed ID: 26225991
[TBL] [Abstract][Full Text] [Related]
5. CCR5-targeted hematopoietic stem cell gene approaches for HIV disease: current progress and future prospects.
Lai Y
Curr Stem Cell Res Ther; 2012 Jul; 7(4):310-7. PubMed ID: 22486585
[TBL] [Abstract][Full Text] [Related]
6. The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV.
Karuppusamy KV; Babu P; Thangavel S
Stem Cell Rev Rep; 2021 Oct; 17(5):1607-1618. PubMed ID: 33788143
[TBL] [Abstract][Full Text] [Related]
7. Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates.
Peterson CW; Wang J; Norman KK; Norgaard ZK; Humbert O; Tse CK; Yan JJ; Trimble RG; Shivak DA; Rebar EJ; Gregory PD; Holmes MC; Kiem HP
Blood; 2016 May; 127(20):2416-26. PubMed ID: 26980728
[TBL] [Abstract][Full Text] [Related]
8. Zinc-finger nucleases make the cut in HIV.
Owens B
Nat Rev Drug Discov; 2014 May; 13(5):321-2. PubMed ID: 24781537
[No Abstract] [Full Text] [Related]
9. CCR5-edited gene therapies for HIV cure: Closing the door to viral entry.
Haworth KG; Peterson CW; Kiem HP
Cytotherapy; 2017 Nov; 19(11):1325-1338. PubMed ID: 28751153
[TBL] [Abstract][Full Text] [Related]
10. Antiretrovirals to CCR5 CRISPR/Cas9 gene editing - A paradigm shift chasing an HIV cure.
Khan A; Paneerselvam N; Lawson BR
Clin Immunol; 2023 Oct; 255():109741. PubMed ID: 37611838
[TBL] [Abstract][Full Text] [Related]
11. Genetically-edited induced pluripotent stem cells derived from HIV-1-infected patients on therapy can give rise to immune cells resistant to HIV-1 infection.
Teque F; Ye L; Xie F; Wang J; Morvan MG; Kan YW; Levy JA
AIDS; 2020 Jul; 34(8):1141-1149. PubMed ID: 32287059
[TBL] [Abstract][Full Text] [Related]
12. Efficient ZFN-Mediated Stop Codon Integration into the CCR5 Locus in Hematopoietic Stem Cells: A Possible Source for Intrabone Marrow Cell Transplantation.
Chattong S; Chaikomon K; Chaiya T; Tangkosakul T; Palavutitotai N; Anusornvongchai T; Manotham K
AIDS Res Hum Retroviruses; 2018 Jul; 34(7):575-579. PubMed ID: 29575905
[TBL] [Abstract][Full Text] [Related]
13. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5.
Mock U; Machowicz R; Hauber I; Horn S; Abramowski P; Berdien B; Hauber J; Fehse B
Nucleic Acids Res; 2015 Jun; 43(11):5560-71. PubMed ID: 25964300
[TBL] [Abstract][Full Text] [Related]
14. Gene Editing of HIV-1 Co-receptors to Prevent and/or Cure Virus Infection.
Allen AG; Chung CH; Atkins A; Dampier W; Khalili K; Nonnemacher MR; Wigdahl B
Front Microbiol; 2018; 9():2940. PubMed ID: 30619107
[TBL] [Abstract][Full Text] [Related]
15. Possible Clues to a Functional Cure for HIV Infection.
Lai Y
Intervirology; 2015; 58(3):181-3. PubMed ID: 26112596
[No Abstract] [Full Text] [Related]
16. Gene Editing Expands the Donor Pool for CCR5-Negative Stem Cell Transplants.
Cannon PM
Cell Stem Cell; 2019 Dec; 25(6):735-736. PubMed ID: 31809736
[TBL] [Abstract][Full Text] [Related]
17. CCR5 Promoter Polymorphism -2459G > A: Forgotten or Ignored?
Mehlotra RK
Cells; 2019 Jun; 8(7):. PubMed ID: 31261839
[TBL] [Abstract][Full Text] [Related]
18. Biology of CCR5 and its role in HIV infection and treatment.
Lederman MM; Penn-Nicholson A; Cho M; Mosier D
JAMA; 2006 Aug; 296(7):815-26. PubMed ID: 16905787
[TBL] [Abstract][Full Text] [Related]
19. CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy.
Allers K; Schneider T
Curr Opin Virol; 2015 Oct; 14():24-9. PubMed ID: 26143158
[TBL] [Abstract][Full Text] [Related]
20. CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy.
Grande F; Occhiuzzi MA; Rizzuti B; Ioele G; De Luca M; Tucci P; Svicher V; Aquaro S; Garofalo A
Molecules; 2019 Feb; 24(3):. PubMed ID: 30717348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
